相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Secondary prevention medications after coronary artery bypass grafting and long-term survival: a population-based longitudinal study from the SWEDEHEART registry
Erik Bjoerklund et al.
EUROPEAN HEART JOURNAL (2020)
The SYNTAX score on its way out or ... towards artificial intelligence: part I
Patrick W. Serruys et al.
EUROINTERVENTION (2020)
The SYNTAX score on its way out or ... towards artificial intelligence: part II
Patrick W. Serruys et al.
EUROINTERVENTION (2020)
A statistical primer on subgroup analyses
Milan Milojevic et al.
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2020)
Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation
Kuniaki Takahashi et al.
LANCET (2020)
Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial
Daniel J. F. M. Thuijs et al.
LANCET (2019)
2017 EACTS Guidelines on perioperative medication in adult cardiac surgery
Miguel Sousa-Uva et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2018)
Optimal Medical Therapy for Known Coronary Artery Disease A Review
Raymond J. Gibbons et al.
JAMA CARDIOLOGY (2017)
Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study
Charles D. Resor et al.
CIRCULATION (2016)
Coronary Artery Bypass Graft Versus Percutaneous Coronary Intervention
Paul Kurlansky et al.
CIRCULATION (2016)
Optimal Medical Therapy Improves Clinical Outcomes in Patients Undergoing Revascularization With Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting Insights From the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial at the 5-Year Follow-Up
Javaid Iqbal et al.
CIRCULATION (2015)
Statistical Controversies in Reporting of Clinical Trials Part 2 of a 4-Part Series on Statistics for Clinical Trials
Stuart J. Pocock et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease
Steven P. Sedlis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease
Stephan D. Fihn et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Adherence to Secondary Prevention Medications and Four-year Outcomes in Outpatients with Atherosclerosis
Dharam J. Kumbhani et al.
AMERICAN JOURNAL OF MEDICINE (2013)
Quantification of Incomplete Revascularization and its Association With Five-Year Mortality in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) Trial Validation of the Residual SYNTAX Score
Vasim Farooq et al.
CIRCULATION (2013)
Effects of a Fixed-Dose Combination Strategy on Adherence and Risk Factors in Patients With or at High Risk of CVD The UMPIRE Randomized Clinical Trial
Simon Thom et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
The Negative Impact of Incomplete Angiographic Revascularization on Clinical Outcomes and Its Association With Total Occlusions
Vasim Farooq et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial
Friedrich W. Mohr et al.
LANCET (2013)
Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery (SYNTAX) trial
Vasim Farooq et al.
EUROPEAN HEART JOURNAL (2012)
A Global Risk Approach to Identify Patients With Left Main or 3-Vessel Disease Who Could Safely and Efficaciously Be Treated With Percutaneous Coronary Intervention The SYNTAX Trial at 3 Years
Patrick W. Serruys et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2012)
Quantification and Impact of Untreated Coronary Artery Disease After Percutaneous Coronary Intervention The Residual SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) Score
Philippe Genereux et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update A Guideline From the American Heart Association and American College of Cardiology Foundation Endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association
Sidney C. Smith et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons
L. David Hillis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions
Glenn N. Levine et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Ten-Year Follow-Up Survival of the Medicine, Angioplasty, or Surgery Study (MASS II) A Randomized Controlled Clinical Trial of 3 Therapeutic Strategies for Multivessel Coronary Artery Disease
Whady Hueb et al.
CIRCULATION (2010)
Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation
Massimo Francesco Piepoli et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2010)
The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction
P. Bramlage et al.
HEART (2010)
Preoperative statin is associated with decreased operative mortality in high risk coronary artery bypass patients
James A. Magovern et al.
JOURNAL OF CARDIOTHORACIC SURGERY (2010)
Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease
Patrick W. Serruys et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Impact of Statin Use on Outcomes After Coronary Artery Bypass Graft Surgery
Alexander Kulik et al.
CIRCULATION (2008)
Statin therapy is associated with reduced total and cardiovascular mortality after coronary artery bypass grafting surgery
Athanasios Papathanasiou et al.
CORONARY ARTERY DISEASE (2008)
Optimal medical therapy with or without PCI for stable coronary disease
William E. Boden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery
Abhinav Goyal et al.
ANNALS OF THORACIC SURGERY (2007)
The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: Design, rationale, and run-in phase
Andrew T. L. Ong et al.
AMERICAN HEART JOURNAL (2006)
Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention - A randomized controlled trial
PWJC Serruys et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
分享论文
